4:16 PM ET
8-K
Capital Raise
Zenas BioPharma Capital Raise
Zenas BioPharma filed a new prospectus supplement to increase its at-the-market (ATM) offering program capacity by $200 million. This replaces a prior supplement under which the company had already sold approximately $153.2 million in common stock, leaving $46.8 million unsold from the previous authorization.
- Counterparty
- Jefferies LLC